FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs
FDA's 2024 guidance on nitrosamine impurities introduces new limits, testing methods, and timelines, focusing on NDSRIs to enhance drug safety and compliance.
Your trusted source for GMP excellence!